DWJ108J

· Daewoong Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DWJ108J, covering 2017-01-24 to 2023-09-06. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate the Efficacy and Safety of DWJ108J [Phase 3]